492 related articles for article (PubMed ID: 33654312)
1. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation.
Tziortzouda P; Van Den Bosch L; Hirth F
Nat Rev Neurosci; 2021 Apr; 22(4):197-208. PubMed ID: 33654312
[TBL] [Abstract][Full Text] [Related]
2. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia.
Archbold HC; Jackson KL; Arora A; Weskamp K; Tank EM; Li X; Miguez R; Dayton RD; Tamir S; Klein RL; Barmada SJ
Sci Rep; 2018 Mar; 8(1):4606. PubMed ID: 29545601
[TBL] [Abstract][Full Text] [Related]
3. TDP43 and RNA instability in amyotrophic lateral sclerosis.
Weskamp K; Barmada SJ
Brain Res; 2018 Aug; 1693(Pt A):67-74. PubMed ID: 29395044
[TBL] [Abstract][Full Text] [Related]
4. Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca
Markovinovic A; Martín-Guerrero SM; Mórotz GM; Salam S; Gomez-Suaga P; Paillusson S; Greig J; Lee Y; Mitchell JC; Noble W; Miller CCJ
Acta Neuropathol Commun; 2024 Feb; 12(1):32. PubMed ID: 38395965
[TBL] [Abstract][Full Text] [Related]
5. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation.
Kreiter N; Pal A; Lojewski X; Corcia P; Naujock M; Reinhardt P; Sterneckert J; Petri S; Wegner F; Storch A; Hermann A
Neurobiol Dis; 2018 Jul; 115():167-181. PubMed ID: 29630989
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
[TBL] [Abstract][Full Text] [Related]
8. An Intramolecular Salt Bridge Linking TDP43 RNA Binding, Protein Stability, and TDP43-Dependent Neurodegeneration.
Flores BN; Li X; Malik AM; Martinez J; Beg AA; Barmada SJ
Cell Rep; 2019 Apr; 27(4):1133-1150.e8. PubMed ID: 31018129
[TBL] [Abstract][Full Text] [Related]
9. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
[TBL] [Abstract][Full Text] [Related]
10. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis.
Suk TR; Rousseaux MWC
Mol Neurodegener; 2020 Aug; 15(1):45. PubMed ID: 32799899
[TBL] [Abstract][Full Text] [Related]
11. Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD.
Khalil B; Linsenmeier M; Smith CL; Shorter J; Rossoll W
Mol Neurodegener; 2024 Jan; 19(1):8. PubMed ID: 38254150
[TBL] [Abstract][Full Text] [Related]
12. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
Vanden Broeck L; Callaerts P; Dermaut B
Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
[TBL] [Abstract][Full Text] [Related]
13. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
14. Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity.
Kitamura A; Nakayama Y; Shibasaki A; Taki A; Yuno S; Takeda K; Yahara M; Tanabe N; Kinjo M
Sci Rep; 2016 Jan; 6():19230. PubMed ID: 26757674
[TBL] [Abstract][Full Text] [Related]
15. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia.
Pasetto L; Grassano M; Pozzi S; Luotti S; Sammali E; Migazzi A; Basso M; Spagnolli G; Biasini E; Micotti E; Cerovic M; Carli M; Forloni G; De Marco G; Manera U; Moglia C; Mora G; Traynor BJ; Chiò A; Calvo A; Bonetto V
Brain; 2021 Dec; 144(12):3710-3726. PubMed ID: 34972208
[TBL] [Abstract][Full Text] [Related]
16. TDP43 ribonucleoprotein granules: physiologic function to pathologic aggregates.
Corbet GA; Wheeler JR; Parker R; Weskamp K
RNA Biol; 2021 Oct; 18(sup1):128-138. PubMed ID: 34412568
[TBL] [Abstract][Full Text] [Related]
17. A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects.
Ricketts T; McGoldrick P; Fratta P; de Oliveira HM; Kent R; Phatak V; Brandner S; Blanco G; Greensmith L; Acevedo-Arozena A; Fisher EM
PLoS One; 2014; 9(1):e85962. PubMed ID: 24465814
[TBL] [Abstract][Full Text] [Related]
18. Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy.
Khalil B; Chhangani D; Wren MC; Smith CL; Lee JH; Li X; Puttinger C; Tsai CW; Fortin G; Morderer D; Gao J; Liu F; Lim CK; Chen J; Chou CC; Croft CL; Gleixner AM; Donnelly CJ; Golde TE; Petrucelli L; Oskarsson B; Dickson DW; Zhang K; Shorter J; Yoshimura SH; Barmada SJ; Rincon-Limas DE; Rossoll W
Mol Neurodegener; 2022 Dec; 17(1):80. PubMed ID: 36482422
[TBL] [Abstract][Full Text] [Related]
19. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
[TBL] [Abstract][Full Text] [Related]
20. Modulation of assembly of TDP-43 low-complexity domain by heparin: From droplets to amyloid fibrils.
Garg DK; Bhat R
Biophys J; 2022 Jul; 121(13):2568-2582. PubMed ID: 35644946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
